Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5107-5114

  Lo, Ying Chun ^a   Edidin, Michael A ^b,c   Powell, Jonathan D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; NANOPARTICLE; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; IMMUNOTHERAPY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ADOPTIVE TRANSFER; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; VACCINATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NANOPARTICLES; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; VACCINATION;

EID: 84887457580     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301433     Document Type: Article

References (34)

1. Bonilla, F. A., and H. C. Oettgen. 2010. Adaptive immunity. J. Allergy Clin. Immunol. 125 (Suppl 2):S33-S40.
2. Litman, G. W., J. P. Rast, and S. D. Fugmann. 2010. The origins of vertebrate adaptive immunity. Nat. Rev. Immunol. 10:543-553.
3. Davis, M. M., and P. J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395-402.
4. Dustin, M. L., and J. T. Groves. 2012. Receptor signaling clusters in the immune synapse. Annu Rev Biophys 41:543-556.
5. Fahmy, T. M., J. G. Bieler, M. Edidin, and J. P. Schneck. 2001. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 14:135-143.
6. Zhong, L., G. Zeng, X. Lu, R. C. Wang, G. Gong, L. Yan, D. Huang, and Z. W. Chen. 2009. NSOM/QD-based direct visualization of CD3-induced and CD28-enhanced nanospatial coclustering of TCR and coreceptor in nanodomains in T cell activation. PLoS ONE 4:e5945.
7. Anikeeva, N., D. Gakamsky, J. Schøller, and Y. Sykulev. 2012. Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling. PLoS ONE 7:e41466.
8. Fernández-Miguel, G., B. Alarcón, A. Iglesias, H. Bluethmann, M. Alvarez-Mon, E. Sanz, and A. De La Hera. 1999. Multivalent structure of an alphabetaT cell receptor. Proc. Natl. Acad. Sci. USA 96:1547-1552.
9. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285:221-227.
10. Minguet, S., M. Swamy, B. Alarcón, I. F. Luescher, and W. W. Schamel. 2007. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 26:43-54.
11. Schamel, W. W., I. Arechaga, R. M. Risueño, H. M. Van Santen, P. Cabezas, C. Risco, J. M. Valpuesta, and B. Alarcón. 2005. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J. Exp. Med. 202:493-503.
12. Huppa, J. B., M. Axmann, M. A. Mörtelmaier, B. F. Lillemeier, E. W. Newell, M. Brameshuber, L. O. Klein, G. J. Schütz, and M. M. Davis. 2010. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 463:963-967.
13. Kumar, R., M. Ferez, M. Swamy, I. Arechaga, M. T. Rejas, J. M. Valpuesta, W. W. Schamel, B. Alarcon, and H. M. Van Santen. 2011. Increased sensitivity of antigen-experienced T cells through the enrichment of oligomeric T cell receptor complexes. Immunity 35:375-387.
14. Alivisatos, P. 2004. The use of nanocrystals in biological detection. Nat. Biotechnol. 22:47-52.
15. Mattoussi, H., J. M. Mauro, E. R. Goldman, G. P. Anderson, V. C. Sundar, F. V. Mikulec, and M. G. Bawendi. 2000. Self-assembly of CdSe-ZnS quantum dot bioconjugates using an engineered recombinant protein. J. Am. Chem. Soc. 122:12142-12150.
16. Boyle, S., D. L. Kolin, J. G. Bieler, J. P. Schneck, P. W. Wiseman, and M. Edidin. 2011. Quantum dot fluorescence characterizes the nanoscale organization of T cell receptors for antigen. Biophys. J. 101:L57-L59.
17. Lillemeier, B. F., M. A. Mörtelmaier, M. B. Forstner, J. B. Huppa, J. T. Groves, and M. M. Davis. 2010. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat. Immunol. 11:90-96.
18. Bruchez, M., Jr., M. Moronne, P. Gin, S. Weiss, and A. P. Alivisatos. 1998. Semiconductor nanocrystals as fluorescent biological labels. Science 281:2013-2016.
19. Hotz, C. Z. 2005. Applications of quantum dots in biology: an overview. Methods Mol. Biol. 303:1-17.
20. Michalet, X., F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. Sundaresan, A. M. Wu, S. S. Gambhir, and S. Weiss. 2005. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307:538-544.
21. Tanaka, K. A., K. G. Suzuki, Y. M. Shirai, S. T. Shibutani, M. S. Miyahara, H. Tsuboi, M. Yahara, A. Yoshimura, S. Mayor, T. K. Fujiwara, and A. Kusumi. 2010. Membrane molecules mobile even after chemical fixation. Nat. Methods 7:865-866.
22. Meuer, S. C., R. E. Hussey, D. A. Cantrell, J. C. Hodgdon, S. F. Schlossman, K. A. Smith, and E. L. Reinherz. 1984. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc. Natl. Acad. Sci. USA 81:1509-1513.
23. Van Wauwe, J. P., J. R. De Mey, and J. G. Goossens. 1980. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J. Immunol. 124:2708-2713.
24. Cho, N. H., T. C. Cheong, J. H. Min, J. H. Wu, S. J. Lee, D. Kim, J. S. Yang, S. Kim, Y. K. Kim, and S. Y. Seong. 2011. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6:675-682.
25. Sun, C., J. S. Lee, and M. Zhang. 2008. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 60:1252-1265.
26. Klippstein, R., and D. Pozo. 2010. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine 6:523-529.
27. Hamdy, S., A. Haddadi, A. Shayeganpour, J. Samuel, and A. Lavasanifar. 2011. Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles. Pharm. Res. 28:2288-2301.
28. Hirosue, S., I. C. Kourtis, A. J. Van Der Vlies, J. A. Hubbell, and M. A. Swartz. 2010. Antigen delivery to dendritic cells by poly (propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. Vaccine 28:7897-7906.
29. Jewell, C. M., S. C. López, and D. J. Irvine. 2011. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc. Natl. Acad. Sci. USA 108:15745-15750.
30. Nembrini, C., A. Stano, K. Y. Dane, M. Ballester, A. J. Van Der Vlies, B. J. Marsland, M. A. Swartz, and J. A. Hubbell. 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc. Natl. Acad. Sci. USA 108:E989-E997.
31. Pathak, S., M. C. Davidson, and G. A. Silva. 2007. Characterization of the functional binding properties of antibody conjugated quantum dots. Nano Lett. 7:1839-1845.
32. Davis, S. J., and P. A. Van Der Merwe. 2006. The kinetic-segregation model: TCR triggering and beyond. Nat. Immunol. 7:803-809.
33. Maloney, D. G., A. J. Grillo-López, C. A. White, D. Bodkin, R. J. Schilder, J. A. Neidhart, N. Janakiraman, K. A. Foon, T. M. Liles, B. K. Dallaire, et al. 1997. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188-2195.
34. Anderson, K. C., M. P. Bates, B. L. Slaughenhoupt, G. S. Pinkus, S. F. Schlossman, and L. M. Nadler. 1984. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 63:1424-1433.